Details
Stereochemistry | ACHIRAL |
Molecular Formula | C28H44NO2 |
Molecular Weight | 426.6545 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 1 |
SHOW SMILES / InChI
SMILES
CC1=CC(=CC=C1OCCOCC[N+](C)(C)CC2=CC=CC=C2)C(C)(C)CC(C)(C)C
InChI
InChIKey=UQOOPIMXBSPVJI-UHFFFAOYSA-N
InChI=1S/C28H44NO2/c1-23-20-25(28(5,6)22-27(2,3)4)14-15-26(23)31-19-18-30-17-16-29(7,8)21-24-12-10-9-11-13-24/h9-15,20H,16-19,21-22H2,1-8H3/q+1
Benzyldimethyl(2-(2-((4-(1,1,3,3-Tetramethylbutyl)-O-Tolyl)Oxy)Ethoxy)Ethyl)Ammonium colloquially known as Methylbenzethonium Chloride has been used in the study stem cell death-inducing small molecules as well as anti-leishmanial activity. It is a component of the pharmaceutical preparation 'Leshctan' antibacterial ointment in Isreal.
Approval Year
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | Leshcutan Approved UseApproved for use as an active ingredient in the pharmaceutical preparation of Leshcutan in Isreal. |
|||
Primary | Leshcutan Approved UseApproved for use as an active ingredient in the pharmaceutical preparation of Leshcutan in Isreal. |
PubMed
Title | Date | PubMed |
---|---|---|
Occupational allergic contact dermatitis from alkylammonium amidobenzoate. | 2001 May-Jun |
|
Comparison of the effectiveness of two topical paromomycin treatments versus meglumine antimoniate for New World cutaneous leishmaniasis. | 2004 Jul |
|
Purification and characterization of an extracellular lipase from Geotrichum marinum. | 2004 Mar |
|
Optimization of topical therapy for Leishmania major localized cutaneous leishmaniasis using a reliable C57BL/6 Model. | 2007 Nov 28 |
|
Interventions for American cutaneous and mucocutaneous leishmaniasis. | 2009 Apr 15 |
|
Cell-based and cytokine-directed chemical screen to identify potential anti-multiple myeloma agents. | 2010 Jul |
|
Drug resistance in leishmaniasis. | 2010 May |
Sample Use Guides
Methylbenzethonium Chloride is included in commercial preparations of Leshcutan ointment at a concentration of 12%. The label instructions indicate to apply ointment twice daily for about 10 days.
Route of Administration:
Topical
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/21617963
Mouse CGR8 embryonic stem cells (ESCs), adapted to grow in the absence of feeder cells, were cultured in Glasgow Minimum Essential Medium supplemented with 10 % bovine serum, 100 units/mL leukemia inhibitory factor, 50 micro-M beta-mercaptoethanol, and 100 U/mL of penicillin/streptomycin and temperature controlled at 37 deg-C in a 5% CO2 atmosphere. Cells were distributed in a 96 well plate and screened against a library of small molecules at a final concentration of 10 micro-M per compound. Cultures were incubated with compounds for 48 hours prior to measuring cell viability by XTT colorimetric assay. Compound 199A was identified as methylbenzethonium chloride and was among those that killed or significantly attenuated the cell growth. An LD50 for methylbenzethonium chloride was determined to be 20 micro-M.
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
4135
Created by
admin on Fri Dec 15 18:09:49 GMT 2023 , Edited by admin on Fri Dec 15 18:09:49 GMT 2023
|
PRIMARY | |||
|
NJX1653L36
Created by
admin on Fri Dec 15 18:09:49 GMT 2023 , Edited by admin on Fri Dec 15 18:09:49 GMT 2023
|
PRIMARY | |||
|
72013-76-4
Created by
admin on Fri Dec 15 18:09:49 GMT 2023 , Edited by admin on Fri Dec 15 18:09:49 GMT 2023
|
PRIMARY | |||
|
DTXSID20865274
Created by
admin on Fri Dec 15 18:09:49 GMT 2023 , Edited by admin on Fri Dec 15 18:09:49 GMT 2023
|
PRIMARY |